Lipotoxicity and Maintenance of Metabolic Health
- Institution
- JOSLIN DIABETES CENTER, MA
- Principal investigator
- Jean E. Schaffer
- Funding
- $595K
- Duration
- 2023–2027
Moonbase score
Still being scored
Abstract
ABSTRACT Lipotoxicity is an important mechanism of complications in type 2 diabetes, including non-alcoholic fatty liver disease (NAFLD). Through a genetic screen, we discovered that loss of small nucleolar RNAs (snoRNAs) embedded within introns of the ribosomal protein L13a (Rpl13a) locus confers resistance to lipotoxicity in a cell culture model. The four Rpl13a snoRNAs, SNORD32A, SNORD33, SNORD34, and SNORD35A, guide 2¢-O- methyl nucleotide modifications at five sites on nascent 18S and 28S ribosomal RNAs that lie in close proximity to key functional centers of the ribosome structure. This study will test the hypothesis that knockout of Rpl13a snoRNAs protects from lipotoxic tissue damage in a mouse model of high fat diet-induced NAFLD. We will define the mechanistic links among snoRNA abundance, mRNA translation, and dietary nutrient exposures. Findings from this work will provide new insights into the pathophysiology of NAFLD and other diseases of lipid overload and have the potential to identify new therapeutic targets for treatment of metabolic diseases.
LOADING MOONBASE SCORE
Questions for JOSLIN DIABETES CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Joslin Diabetes CenterNot yet scored
Translational Programming of Beta-cells in Response to Glucose Toxicity
Jean E. Schaffer · $707K · 2024–2027
- NIH · Joslin Diabetes CenterNot yet scored
Joslin-BIDMC Postbac Program in Diabetes and Metabolism
Jean E. Schaffer · $390K · 2024–2028
- NIH · Joslin Diabetes CenterNot yet scored
Homeostasis functions of SKN-1A/Nrf1
Jean E. Schaffer · $515K · 2017–2028